OP54 Sequential Interventions And Cost-Minimization Analysis To Promote Disinvestment In Intravenous Immunoglobulin For Immune Deficiencies At A Pediatric Hospital
Graciela Demirdjian, Marcela Rousseau · 2025
Read OP54 Sequential Interventions And Cost-Minimization Analysis To Promote Disinvestment In Intravenous Immunoglobulin For Immune Deficiencies At A Pediatric Hospital by Graciela Demirdjian, Marcela Rousseau (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12768815.txt.
Description
Graciela Demirdjian and Marcela Rousseau wrote a 2025 study on cutting the cost of an immune treatment at a children's hospital in Argentina. The drug, immunoglobulin G, had topped the pharmacy bill since 2015. Its share of drug spending rose from 16 percent in 2018 to 27 percent in 2023.
The hospital's review unit wrote a guide for sound use of the drug in children with weak immune systems. The guide found that the form given under the skin works as well as the form given into a vein. At first the under-skin form cost more, so the switch was dropped. As its price fell over time, fresh cost checks were run with real hospital data. The study shows how step-by-step checks can curb waste without harming care.
Catalog record
| CREATOR | Graciela Demirdjian, Marcela Rousseau |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |